Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

After hours: February 14 at 7:45:48 PM EST Loading Chart for NVS ...

Mark Travers, Ph.D., is an American psychologist who writes about psycho-educational topics such as happiness, relationships, personality, and life meaning. He holds degrees from Cornell ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

China hoped to increase “political trust” and belt and road cooperation with the Cook Islands, Premier Li Qiang told his visiting counterpart Mark Brown when they met on Friday. Multiple ...

The Safe Center LI, for more than a decade the major provider of services to Nassau County’s survivors of domestic violence, sexual assault and child abuse, faces dire financial difficulties and ...

with the lead indication for prevention of stroke and systemic embolism in patients with atrial fibrillationAcquisition adds a late-stage asset and is aligned with Novartis strategic focus ...

Job Title Sort ascending Business Location Site Date Posted Consultor Técnico Especialidades Sênior Regular (Vendas), Full time Innovative Medicines Brazil Santo Amaro Feb 05, 2025 MSL, Temporary ...

Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 1,981.81 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Apple's upcoming budget iPhone might not be called the iPhone SE 4 after all, with Bloomberg's Mark Gurman lending credence to rumors of a potential name change for the device being unveiled this ...